Skip to main content

About CRUK Scotland Institute

Find out what we do, how we do it and why we do what we do.

A person walks across a city street at sunset, with tall buildings lining the road on both sides.

Life in Glasgow

Find out about living and working in Glasgow and Scotland.

Our Research

Explore the science at CRUK Scotland Institute. Our research groups, the people who lead them, and how we work.

Operations

The teams and services that keep the Institute running and support our research.

Partners

The networks and organisations we work with to accelerate cancer research.

Careers & Study

Jobs, studentships and opportunities for students at every stage at our world-renowned cancer research institute.

Studentships

PhD opportunities at the Institute

Studentship Vacancies

Open studentships to apply for

Internships

For undergraduate and masters students

Translational Molecular Imaging

Group Leader:
Prof David Lewis

Translating Imaging Science into Impact — the TMI Facility develops and deploys cutting-edge PET/MRI technologies, radiotracers, and analytics for cancer research and clinical translation. The Translational Molecular Imaging (TMI) Facility, led by Prof David Lewis, advances novel imaging technologies and serves as a shared resource for researchers across the CRUK Scotland Institute and Scotland Cancer Centre. As a hub for emerging imaging science, TMI connects preclinical discovery to clinical implementation. We specialise in novel PET probes, imageable transgenic models, multi-tracer workflows, and AI-enabled analytics integrated with spatial-omics. TMI supports everything from facilitated scanning to fully collaborative development of imaging agents and pharmacodynamic biomarkers. Our work targets metabolic heterogeneity and systemic metabolism (e.g., cachexia), delivering non-invasive biomarkers for classification, patient stratification, therapy guidance, and clinical translation.

Blue icon of a document with horizontal lines representing text and a folded bottom right corner, on a light grey background.

Recent Publications

click here to read
A pink icon of three people on a light grey background, with one person in front and two slightly behind on either side, representing a group or community.

Lab Members

click here to read

Recent Publications

2024

Hesketh, R. L.; Lewis, D. Y.; Brindle, K. M. (2024). Optimisation of Animal Handling and Timing of 2-deoxy-2-[18F] fluoro-D-glucose PET Tumour Imaging in Mice. Molecular Imaging and Biology, 26 (6), 965-976.

2023

Villar, V. H., Allega, M. F., Deshmukh, R., Ackermann, T., Nakasone, M. A.; Vande Voorde, J., Drake, T. M., Oetjen, J. Bloom, A., Nixon, C. (2023). Hepatic glutamine synthetase controls N5-methylglutamine in homeostasis and cancer. Nature Chemical Biology. 19 (3), 292-300.

Lewis, D. Y. (2023). Multiplexing Autoradiography. Positron Emission Tomography: Methods and Protocols. 423-439.

Brown, G., Solovyev, D., Lewis, D. (2023). Radiosynthesis and analysis of (S)-4-(3-[18F] fluoropropyl)-L-glutamic acid. Nuclear Medicine and Biology. 126, S73-S74.

2022

Soloviev, D., Dzien, P., Mackintosh, A., Malviya, G., Brown, G., Lewis, D. (2022). High molar activity [18F] tetrafluoroborate synthesis for sodium iodide symporter imaging by PET. EJNMMI Radiopharmacy and Chemistry. 7 (1), 32.

2020

Malviya, G., Patel, R., Salji, M., Martinez, R. S., Repiscak, P., Mui, E., Champion, S., Mrowinska, A., Johnson, E., AlRasheedi, M. (2020). 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy. EJNMMI Research. 10 (1), 143.

2019

Witney, T. H., Lewis, D. Y. (2019). Imaging cancer metabolism with positron emission tomography (PET). Cancer Metabolism: Methods and Protocols. 29-44.

2018

Zmuda, F., Blair, A., Liuzzi, M. C., Malviya, G., Chalmers, A. J., Lewis, D., Sutherland, A., Pimlott, S. L. (2018). An 18F-labeled poly (ADP-ribose) polymerase positron emission tomography imaging agent. Journal of Medicinal Chemistry. 61 (9), 4103-4114.

Group Leader

A man with short light brown hair and a trimmed beard, wearing a white collared shirt, poses against a plain light grey background, softly smiling at the camera.

Lab Members

PET Research Development Manager

A young woman with long brown hair and a black shirt smiles at the camera, against a plain light background.

Una Goncin

I leverage extensive expertise in project management, multimodal imaging, clinical trial management, and communications to drive the growth and impact of PET research in Glasgow. In my role, I lead the development, implementation, and oversight of PET imaging strategy, ensuring operational excellence, resource optimisation, and regulatory My role includes building collaborations, supporting and securing research funding, and creating opportunities for translational success. I lead marketing and outreach initiatives to raise the profile of PET research and ensure its long-term sustainability.

Email me

Senior Scientific Officer

A person with curly dark hair and a nose ring smiling at the camera.

Carol McMenemy

I am a preclinical researcher with expertise in cancer biology and laboratory management. I’m experienced in in vivo cancer modelling, most recently with orthotopic models of PDAC, where I use multiplexed IF to study the TME and TiME. In my current role, I support PET/MRI imaging programmes, integrating molecular imaging, histopathology, and transgenic disease models to understand disease biology, while contributing to the development, operation, and day-to-day management of molecular imaging facilities.

Email me

Head of Radiochemistry

An older man with grey hair and glasses, wearing a checked shirt, stands outdoors in a mountainous area with green hills and patches of snow in the background.

Dmitry Soloviev

As Head of Radiochemistry, I lead radiochemistry efforts supporting PET imaging studies across Scotland, driving innovation in molecular imaging. My team has extensive expertise in radiopharmaceutical development, short-lived positron-emitting radionuclides, and advanced radiolabelling techniques. We specialize in radiolabelling metabolites to uncover cancer biochemistry and the interplay between disease biology and imaging.

By advancing preclinical and clinical PET studies, we help researchers translate discoveries into real-world impact.

Email me

Secret Link